@Jota5571189851 Avatar @Jota5571189851 Jota557

Jota557 posts on X about $sgmo, oracle, cart, money the most. They currently have [-----] followers and [--] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-----] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence finance technology brands stocks social networks

Social topic influence $sgmo, oracle, cart, money, short interest, buying, volume, how to, field, this is

Top accounts mentioned or mentioned by @biotechanalysst @thatgirltrader @grok @zinselmeyerb @eipaas @soerenberlin @francaole @mitchellreed09 @tradernorway @gothamgirl1 @fitzdad55 @petrr1763390 @hanakamatsu @zay111086718 @unionsteel2017 @coronanlyme @bambossie81 @heartratetrader @thecryptomaze @elijahwc

Top assets mentioned Beyond Meat, Inc. (BYND) ImmunityBio, Inc. Common Stock (IBRX) uniQure N.V. (QURE) Wave Life Sciences Ltd. Ordinary Shares (WVE) Arrowhead Research Corporation (ARWR) Ventyx Biosciences, Inc. (VTYX)

Top Social Posts

Top posts by engagements in the last [--] hours

"@thatgirltrader Hey @grok why marketwatch showing only 10% float shorted while oracle showing 108%"
X Link 2025-10-23T22:02Z [--] followers, [---] engagements

"@EiPaas @thatgirltrader @grok how often does marketwatch and oracle update their data regarding short interest"
X Link 2025-10-23T22:08Z [--] followers, [---] engagements

"@PetrR1763390 @Han_Akamatsu @grok can you please confirm this"
X Link 2025-10-24T13:02Z [--] followers, [--] engagements

"@zay111086718 @BiotechAnalysst I been following his posts I think oracle one is most bullish of all They are healthcare hedge fund from what i know They did own sgmo back in 2018"
X Link 2025-11-19T13:22Z [--] followers, [---] engagements

"@UnionSteel2017 Leme put it this way Once they resolve their cash problem (which i think they wil) Then market will rerate $sgmo based on their platform IMO next year will be big for them"
X Link 2025-12-08T11:56Z [--] followers, [---] engagements

"@Corona_N_Lyme @Franca_ole @BiotechAnalysst This is huge Basically all the companies building next-gen allogeneic CAR-T cells may need to pay SGMO redesign their tech or accept IP risk"
X Link 2026-01-06T13:39Z [--] followers, [---] engagements

"@Franca_ole By filing this patent in May [----] and having it granted years later $SGMO demonstrated it had already mapped out the future architecture of allogeneic CAR-T before much of the industry got there This shows $sgmo is not only about fabry they think way ahead"
X Link 2026-01-06T13:53Z [--] followers, [----] engagements

"@BAMBossie81 Why about your price prediction for $sgmo"
X Link 2026-01-16T02:31Z [--] followers, [---] engagements

"@HeartRateTrader 27% up to 17% down"
X Link 2026-02-09T14:40Z [--] followers, [----] engagements

"Here is the reason why everyone checking on marketwatch and saying short interest is only 10% $Bynd @Jota5571189851 @EiPaas @thatgirltrader MarketWatch updates short interest data bi-monthly based on FINRA reports (typically around the 15th and month-end published shortly after). Ortex (assuming that's what you meant by "oracle") provides daily estimated short interest updates around 7:30-10:30 AM ET alongside @Jota5571189851 @EiPaas @thatgirltrader MarketWatch updates short interest data bi-monthly based on FINRA reports (typically around the 15th and month-end published shortly after)."
X Link 2025-10-23T22:10Z [--] followers, [---] engagements

"$Sgmo Remember tmr is thanksgiving Volume short interest institutions buying rolling bla all point in one direction LFG"
X Link 2025-11-26T16:33Z [--] followers, [---] engagements

"IMO If $sgmo are planning to go alone for fabry then they are obligated to share the news to the investors Plus in earning call and acceptance of rolling bla they mentioned DISCUSSIONS and PARTNERS both plural So there might be multiple parties involved"
X Link 2025-12-18T13:41Z [--] followers, [---] engagements

"RT @BiotechAnalysst: well i voted $SGMO against the $1 rule . so i demand you skip this $1 rule Anyone elso wanting this $1 rule dow"
X Link 2025-12-31T14:16Z [--] followers, [--] engagements

"$sgmo what is this price action"
X Link 2026-01-06T13:31Z [--] followers, [---] engagements

"This $sgmo patent is big because it protects the core engineering method behind off-the-shelf CAR-T cells including how to evade immune destruction. It was conceived years ahead of the field has now been officially granted and gives Sangamo enforceable leverage in a multibillion-dollar area all without SGMO needing to build or fund a CAR-T drug itself. How big is this REALLY Lets size it properly. https://twitter.com/i/web/status/2008554416438165704 https://twitter.com/i/web/status/2008554416438165704"
X Link 2026-01-06T15:01Z [--] followers, [----] engagements

"Market this patent touches Allogeneic CAR-T Off-the-shelf immune cell therapies Next-gen T-cell and NK-cell products This is a multi-tens-of-billions-dollar space over time. $SGMO owns toll-booth IP on a highway the industry is moving toward https://twitter.com/i/web/status/2008554913727467937 https://twitter.com/i/web/status/2008554913727467937"
X Link 2026-01-06T15:03Z [--] followers, [----] engagements

"Why NK evasion matters so much (key point) Allogeneic CAR-T has one huge problem: The patients immune system (especially NK cells) kills the infused CAR-T cells. If you dont solve NK evasion: CAR-T cells dont persist efficacy drops commercial viability collapses This patent covers how to engineer around that problem at the DNA level. Thats a make-or-break issue for the entire field"
X Link 2026-01-06T15:05Z [--] followers, [---] engagements

"$sgmo Almost [--] million volume in premarket and its up 10% This is not normal"
X Link 2026-01-29T13:18Z [--] followers, [----] engagements

"$sgmo Like seriously wtf is this price action 24% without news Can someone explain"
X Link 2026-01-29T14:55Z [--] followers, [----] engagements

"$sgmo tmr could be the day we all been waiting for As we all know by now how much sandy loves Tuesdays"
X Link 2026-02-02T16:27Z [--] followers, [----] engagements

"$sgmo I have few questions [--]. Howcome stock ran up almost 70% up last week(i was thinking that deal news got leaked) clearly someone was buying [--]. What about that temp comms manager role to provide senior-level corporate communications leadership during a period of transition ensuring clear compliant and consistent messaging to employees investors media and partners Anyone have idea what this mean"
X Link 2026-02-03T18:00Z [--] followers, [----] engagements

"$sgmo I just dont get it As we can all see data is clean Why the hell will you choose to dilute before the good data and not after I am pretty sure after this data stock would have been gone up more Anyways what are the options ahead I can see r/s still they will need money ahead for neurology Can they get some loan or other thing"
X Link 2026-02-04T00:17Z [--] followers, [----] engagements

"$sgmo Lets talk about some facts here If sandy is planning to do reverse spilt ( which most likely wont be approved by shareholders as they already said in offering) With an April [--] deadline expect a reverse-split proxy sometime between late February and early March If we dont see anything by then company is either betting on organic price recovery or negotiating an alternative Or they will get delisted (which i dont think will happen personally) NFA"
X Link 2026-02-04T18:15Z [--] followers, [---] engagements

"So basically i dont think they will try for reverse spilt as they know it will be rejected Either bring True binary event now Either bring money thru any non diluted way or get delisted"
X Link 2026-02-04T18:19Z [--] followers, [---] engagements

"$sgmo @Soeren_Berlin @ZinselmeyerB @BiotechAnalysst Reverse split feels unlikely to me. With around [--] months on the clock theres no time for new strategies boards decide these things well in advance. SGMO already knows what its going to do. The next move was likely locked weeks ago. the company has already decided which path its taking good or bad. No point of giving them suggestions now"
X Link 2026-02-05T11:07Z [--] followers, [---] engagements

"$sgmo Cfo left interim cfo Melinda from ir left in jan temp senior communication manager in place I dont know what to think of this What are possible theories"
X Link 2026-02-11T02:27Z [--] followers, [----] engagements

"@BiotechAnalysst How does it connects to sgmo"
X Link 2026-01-05T10:46Z [--] followers, [---] engagements

"@MitchellReed09 Abvx πŸ«₯"
X Link 2026-01-27T16:36Z [--] followers, [---] engagements

"@MitchellReed09 I think number shares outstanding does play a role too beam had close to 105m And $sgmo is [--] times of that"
X Link 2026-01-27T16:39Z [--] followers, [---] engagements

"@TheCryptoMaze $sgmo alot of people are mad at sandy today lol Anyways i think we will know by earnings for sure Only thing they will announce before WORLD symposium is their thing going on with cfo Her last date is [--] jan so they have to tell something about that position"
X Link 2026-01-28T15:53Z [--] followers, [---] engagements

"$sgmo I think we can all just guess and analyze particular piece of information in different ways Sandy said in first earnings call last year that there is alot of interest in fabry and neurology is their priority And these are facts I guess no one can exactly tell what was the hurdle and i think its way too much factors involved than we think Again its guesses when people say no one wants fabry https://twitter.com/i/web/status/2016854039237927416 https://twitter.com/i/web/status/2016854039237927416"
X Link 2026-01-29T12:40Z [--] followers, [---] engagements

"@Soeren_Berlin Is that account @elijahwc and ticker $ibrx"
X Link 2026-01-30T22:40Z [--] followers, [---] engagements

"@ZinselmeyerB $sgmo One thing for sure No one saw this coming And why to do offering before releasing data So many questions and nothing is making sense now"
X Link 2026-02-03T20:01Z [--] followers, [---] engagements

"I think reverse spilt is out of equation as it wont get approved So he has to bring in money or sell company no other way around So we should hear something in 6-8 weeks and it will be really important to see what they have to say in earnings call Personally i dont think they will go to earnings call without any plan https://twitter.com/i/web/status/2019212196450877468 https://twitter.com/i/web/status/2019212196450877468"
X Link 2026-02-05T00:51Z [--] followers, [---] engagements

"@TraderNorway I think market is already pricing in like there is only 10% path forward for $qure With bla I think too that FDA will give unique nod with some requirements with this only we should see price close to [--] atleast imo"
X Link 2026-02-10T10:59Z [--] followers, [---] engagements

"@SP28947316 @JungleJorge2 @BiotechAnalysst @yusufhameed @grok New data best data Competition wasnt even close"
X Link 2026-02-10T14:53Z [--] followers, [--] engagements

"@GothamGirl_1 Why temp now Restructuring"
X Link 2026-02-11T02:28Z [--] followers, [---] engagements

"@TraderNorway They have cash till around june And if they dont do reverse split they will be delisted Btw i expect a deal i am even ok with reverse split i am planning to hold for longtoo much upside to it"
X Link 2026-02-11T20:13Z [--] followers, [--] engagements

"@BiotechAnalysst They underwritten the offering if i recall"
X Link 2026-02-12T14:41Z [--] followers, [---] engagements

"@Fitzdad55 @GothamGirl_1 @BiotechAnalysst $Sgmo I think they know even if release it as PR stock wont move at all unless they show some money before Now i am expecting some sort of deal before earnings and then this in earnings call"
X Link 2026-02-12T18:33Z [--] followers, [---] engagements

"$sgmo Cfo left interim cfo Melinda from ir left in jan temp senior communication manager in place I dont know what to think of this What are possible theories"
X Link 2026-02-11T02:27Z [--] followers, [----] engagements

"$sgmo @Soeren_Berlin @ZinselmeyerB @BiotechAnalysst Reverse split feels unlikely to me. With around [--] months on the clock theres no time for new strategies boards decide these things well in advance. SGMO already knows what its going to do. The next move was likely locked weeks ago. the company has already decided which path its taking good or bad. No point of giving them suggestions now"
X Link 2026-02-05T11:07Z [--] followers, [---] engagements

"$sgmo Lets talk about some facts here If sandy is planning to do reverse spilt ( which most likely wont be approved by shareholders as they already said in offering) With an April [--] deadline expect a reverse-split proxy sometime between late February and early March If we dont see anything by then company is either betting on organic price recovery or negotiating an alternative Or they will get delisted (which i dont think will happen personally) NFA"
X Link 2026-02-04T18:15Z [--] followers, [---] engagements

"So basically i dont think they will try for reverse spilt as they know it will be rejected Either bring True binary event now Either bring money thru any non diluted way or get delisted"
X Link 2026-02-04T18:19Z [--] followers, [---] engagements

"$sgmo I just dont get it As we can all see data is clean Why the hell will you choose to dilute before the good data and not after I am pretty sure after this data stock would have been gone up more Anyways what are the options ahead I can see r/s still they will need money ahead for neurology Can they get some loan or other thing"
X Link 2026-02-04T00:17Z [--] followers, [----] engagements

"$sgmo I have few questions [--]. Howcome stock ran up almost 70% up last week(i was thinking that deal news got leaked) clearly someone was buying [--]. What about that temp comms manager role to provide senior-level corporate communications leadership during a period of transition ensuring clear compliant and consistent messaging to employees investors media and partners Anyone have idea what this mean"
X Link 2026-02-03T18:00Z [--] followers, [----] engagements

"$sgmo tmr could be the day we all been waiting for As we all know by now how much sandy loves Tuesdays"
X Link 2026-02-02T16:27Z [--] followers, [----] engagements

"$sgmo Like seriously wtf is this price action 24% without news Can someone explain"
X Link 2026-01-29T14:55Z [--] followers, [----] engagements

"$sgmo Almost [--] million volume in premarket and its up 10% This is not normal"
X Link 2026-01-29T13:18Z [--] followers, [----] engagements

"This $sgmo patent is big because it protects the core engineering method behind off-the-shelf CAR-T cells including how to evade immune destruction. It was conceived years ahead of the field has now been officially granted and gives Sangamo enforceable leverage in a multibillion-dollar area all without SGMO needing to build or fund a CAR-T drug itself. How big is this REALLY Lets size it properly. https://twitter.com/i/web/status/2008554416438165704 https://twitter.com/i/web/status/2008554416438165704"
X Link 2026-01-06T15:01Z [--] followers, [----] engagements

"Market this patent touches Allogeneic CAR-T Off-the-shelf immune cell therapies Next-gen T-cell and NK-cell products This is a multi-tens-of-billions-dollar space over time. $SGMO owns toll-booth IP on a highway the industry is moving toward https://twitter.com/i/web/status/2008554913727467937 https://twitter.com/i/web/status/2008554913727467937"
X Link 2026-01-06T15:03Z [--] followers, [----] engagements

"Why NK evasion matters so much (key point) Allogeneic CAR-T has one huge problem: The patients immune system (especially NK cells) kills the infused CAR-T cells. If you dont solve NK evasion: CAR-T cells dont persist efficacy drops commercial viability collapses This patent covers how to engineer around that problem at the DNA level. Thats a make-or-break issue for the entire field"
X Link 2026-01-06T15:05Z [--] followers, [---] engagements

"$sgmo what is this price action"
X Link 2026-01-06T13:31Z [--] followers, [---] engagements

"RT @BiotechAnalysst: well i voted $SGMO against the $1 rule . so i demand you skip this $1 rule Anyone elso wanting this $1 rule dow"
X Link 2025-12-31T14:16Z [--] followers, [--] engagements

"well i voted $SGMO against the $1 rule . so i demand you skip this $1 rule Anyone elso wanting this $1 rule down please like this tweet . thank you and Happy New Year πŸŽ‡πŸΎπŸ₯‚ #Biopick2026 contest is officially open for entries. Deadline is eod 2-Jan-26. If interested please fill out an entry form under the link here: https://t.co/AaK21HtHUA Official rules: https://t.co/irMHYN1HRz #Biopick2026 contest is officially open for entries. Deadline is eod 2-Jan-26. If interested please fill out an entry form under the link here: https://t.co/AaK21HtHUA Official rules: https://t.co/irMHYN1HRz"
X Link 2025-12-31T14:09Z [----] followers, [----] engagements

"#Biopick2026 contest is officially open for entries. Deadline is eod 2-Jan-26. If interested please fill out an entry form under the link here: Official rules: https://form.jotform.com/253561239303049 https://form.jotform.com/253561239303049"
X Link 2025-12-23T16:18Z 18.1K followers, 58.2K engagements

"IMO If $sgmo are planning to go alone for fabry then they are obligated to share the news to the investors Plus in earning call and acceptance of rolling bla they mentioned DISCUSSIONS and PARTNERS both plural So there might be multiple parties involved"
X Link 2025-12-18T13:41Z [--] followers, [---] engagements

"The next $WVE $ARWR $VTYX are in biotech. I think the best is $SGMO. Its pipelines and programs will be worth at least 10x once one of them starts to get bought. And I truly believe $SGMO will return 10x from the current depressed level to $5-$10 in 2026"
X Link 2025-12-08T16:51Z [----] followers, [----] engagements

"$Sgmo Remember tmr is thanksgiving Volume short interest institutions buying rolling bla all point in one direction LFG"
X Link 2025-11-26T16:33Z [--] followers, [---] engagements

"$SGMO should see $1 πŸ”œ"
X Link 2025-11-24T14:33Z [---] followers, [----] engagements

"Here is the reason why everyone checking on marketwatch and saying short interest is only 10% $Bynd @Jota5571189851 @EiPaas @thatgirltrader MarketWatch updates short interest data bi-monthly based on FINRA reports (typically around the 15th and month-end published shortly after). Ortex (assuming that's what you meant by "oracle") provides daily estimated short interest updates around 7:30-10:30 AM ET alongside @Jota5571189851 @EiPaas @thatgirltrader MarketWatch updates short interest data bi-monthly based on FINRA reports (typically around the 15th and month-end published shortly after)."
X Link 2025-10-23T22:10Z [--] followers, [---] engagements

"MarketWatch updates short interest data bi-monthly based on FINRA reports (typically around the 15th and month-end published shortly after). Ortex (assuming that's what you meant by "oracle") provides daily estimated short interest updates around 7:30-10:30 AM ET alongside official bi-monthly data"
X Link 2025-10-23T22:08Z 8M followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing